These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14514133)

  • 41. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
    Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
    Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construct validity of selected Automated Neuropsychological Assessment Metrics (ANAM) battery measures.
    Kabat MH; Kane RL; Jefferson AL; DiPino RK
    Clin Neuropsychol; 2001 Dec; 15(4):498-507. PubMed ID: 11935451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis.
    Rayes HA; Tani C; Kwan A; Marzouk S; Colosimo K; Medina-Rosas J; Mustafa A; Su J; Lambiris P; Mosca M; Touma Z
    Semin Arthritis Rheum; 2018 Oct; 48(2):240-255. PubMed ID: 29571540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive impairment in systemic lupus erythematosus: a follow-up study.
    Carlomagno S; Migliaresi S; Ambrosone L; Sannino M; Sanges G; Di Iorio G
    J Neurol; 2000 Apr; 247(4):273-9. PubMed ID: 10836619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.
    Glanz BI; Slonim D; Urowitz MB; Gladman DD; Gough J; MacKinnon A
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):232-8. PubMed ID: 9359119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial systemic lupus erythematosus: a comparison of clinical manifestations and antibody presentation in three ethnic groups.
    Quintero-Del-Rió AI; Bacino D; Kelly J; Aberle T; Harley JB
    Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1223-7. PubMed ID: 11838971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus.
    Ross GS; Zelko F; Klein-Gitelman M; Levy DM; Muscal E; Schanberg LE; Anthony K; Brunner HI;
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1029-33. PubMed ID: 20589693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement invariance of neuropsychological tests in diverse older persons.
    Mungas D; Widaman KF; Reed BR; Tomaszewski Farias S
    Neuropsychology; 2011 Mar; 25(2):260-269. PubMed ID: 21381830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics?
    Weissberger GH; Salmon DP; Bondi MW; Gollan TH
    Neuropsychology; 2013 May; 27(3):343-355. PubMed ID: 23688216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Executive dysfunction, obsessive-compulsive symptoms, and attention deficit and hyperactivity disorder in Systemic Lupus Erythematosus: Evidence for basal ganglia dysfunction?
    Maciel RO; Ferreira GA; Akemy B; Cardoso F
    J Neurol Sci; 2016 Jan; 360():94-7. PubMed ID: 26723981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability.
    Bertoli AM; Fernández M; Alarcón GS; Vilá LM; Reveille JD
    Ann Rheum Dis; 2007 Jan; 66(1):12-7. PubMed ID: 16815862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement.
    Alarcón GS; Bastian HM; Beasley TM; Roseman JM; Tan FK; Fessler BJ; Vilá LM; McGwin G;
    Lupus; 2006; 15(1):26-31. PubMed ID: 16482742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits.
    Denburg SD; Carbotte RM; Denburg JA
    J Clin Exp Neuropsychol; 1987 Aug; 9(4):323-39. PubMed ID: 3597726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing change with the Automated Neuropsychological Assessment Metrics (ANAM): issues and challenges.
    Roebuck-Spencer T; Sun W; Cernich AN; Farmer K; Bleiberg J
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S79-87. PubMed ID: 17118623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
    Kozora E; Ellison MC; West S
    Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.
    Andrade RM; Alarcón GS; Fernández M; Apte M; Vilá LM; Reveille JD;
    Arthritis Rheum; 2007 Feb; 56(2):622-30. PubMed ID: 17265497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project.
    Maningding E; Dall'Era M; Trupin L; Murphy LB; Yazdany J
    Arthritis Care Res (Hoboken); 2020 May; 72(5):622-629. PubMed ID: 31115180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
    Harrison MJ; Ravdin LD; Lockshin MD
    Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients.
    Covey TJ; Shucard JL; Shucard DW; Stegen S; Benedict RH
    J Int Neuropsychol Soc; 2012 May; 18(3):530-40. PubMed ID: 22410107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of ANAM to assess the side-effect profiles and efficacy of medication.
    Wilken JA; Sullivan CL; Lewandowski A; Kane RL
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S127-33. PubMed ID: 17116387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.